Navigation Links
Ambiguity In Patent Laws May Defer New Drug Launches

Indian Government has refused to grant product patent for Glivec, the cancer drug from Novartis AG, the Swiss pharma giant. As a result Novartis may not be able to conduct// their drug research here in India. Singapore and China are the countries where Novartis conducts its research now.

While talking on this issue, Paul Herrling, who heads Corporate Research division of Novartis reveals that this decision by the Indian government could hamper the launch of their patented products. But this in any way will not affect the distribution of Glivec here. According to him, Novartis through its foundation has been distributing Glivec to needy patients to the tune of 1270 crore in India.

Trade analysts opine that if such drugs are not available freely in the market and are being prescribed by the physicians and supplied by a few pharmacies, it would prove to be very expensive to the patients.

Herrling feels that the primary objective of any drug company should be to improve health care services. They should focus their research on this area. Product patent alone is not sufficient but data individuality is more important.
JYT
'"/>




Page: 1

Related medicine news :

1. Botched Abortions Trigger Concern Over Legal Ambiguity In Britain
2. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
3. HIV Patients Opposes Patenting Of AIDS Drug
4. Provigil Patent Extension Accorded To Cephalon
5. AIDS Sufferers Protest against Proposed Patent for Tenofovir
6. POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals
7. Venus Remedies Files 5th International Patent Application
8. US Court Rules Against Lupin in Ramipril Patent Case
9. Patent for Seminal RNAi innovation Cleared in Australia
10. Canada: On Popular Demand, Tamiflu finds a Berth in the Directory of Patent Drugs
11. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... BALTIMORE (PRWEB) , ... October 12, 2017 , ... ... average of $3,296 in property taxes a year. In some states—like New York, ... higher. , By contrast, many overseas retirement havens have extremely low property-tax rates, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: